Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19

NCT04387240 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped did not get enough fund and IRB request

Conditions

Covid 19 Positive
Corona Virus Infection

Interventions

DRUG: Artemisinin / Artesunate
OTHER: placebo

Sponsor

Princess Nourah Bint Abdulrahman University